Western blot analysis indicated that MSCs RUNX2 proteins levels are lower treated with myeloma cells exosomes as compared to untreated cells or healthy plasma cell exosomes treated cells (Figure 6H). Here, RUNX2 is linked to plasma cell myeloma.